- Home
- PAVM vs SSKN Comparison
PAVM vs SSKN Comparison
Compare PAVM & SSKN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PAVM
- SSKN
- Stock Information
- Founded
- PAVM 2014
- SSKN 1989
- Country
- PAVM United States
- SSKN United States
- Employees
- PAVM N/A
- SSKN N/A
- Industry
- PAVM Medical/Dental Instruments
- SSKN Medical/Dental Instruments
- Sector
- PAVM Health Care
- SSKN Health Care
- Exchange
- PAVM Nasdaq
- SSKN Nasdaq
- Market Cap
- PAVM 8.1M
- SSKN 14.5M
- IPO Year
- PAVM 2016
- SSKN 2005
- Fundamental
- Price
- PAVM $1.09
- SSKN $3.26
- Analyst Decision
- PAVM
- SSKN
- Analyst Count
- PAVM 0
- SSKN 0
- Target Price
- PAVM N/A
- SSKN N/A
- AVG Volume (30 Days)
- PAVM 88.6K
- SSKN 9.3K
- Earning Date
- PAVM 08-12-2024
- SSKN 08-14-2024
- Dividend Yield
- PAVM N/A
- SSKN N/A
- EPS Growth
- PAVM N/A
- SSKN N/A
- EPS
- PAVM N/A
- SSKN N/A
- Revenue
- PAVM $3,829,000.00
- SSKN $32,729,999.00
- Revenue This Year
- PAVM $97.06
- SSKN N/A
- Revenue Next Year
- PAVM $294.21
- SSKN $8.71
- P/E Ratio
- PAVM N/A
- SSKN N/A
- Revenue Growth
- PAVM 378.63
- SSKN N/A
- 52 Week Low
- PAVM $0.60
- SSKN $2.51
- 52 Week High
- PAVM $9.00
- SSKN $10.00
- Technical
- Relative Strength Index (RSI)
- PAVM 61.36
- SSKN 49.16
- Support Level
- PAVM $0.80
- SSKN $3.03
- Resistance Level
- PAVM $1.32
- SSKN $3.79
- Average True Range (ATR)
- PAVM 0.11
- SSKN 0.18
- MACD
- PAVM 0.05
- SSKN 0.03
- Stochastic Oscillator
- PAVM 64.62
- SSKN 45.32
About PAVM PAVmed Inc.
PAVmed Inc is a multi-product, commercial-stage medical technology company organized to advance a broad pipeline of medical technologies from concept to commercialization. The Company operates in a single segment as a medical technology company, with the following lines of business: Diagnostics, Medical Devices, and Digital Health. Its products are EsoGuard, esocheck, and the Veris Cancer Care Platform.
About SSKN Strata Skin Sciences Inc.
Strata Skin Sciences Inc is a medical technology company engaged in developing and commercializing products for the treatment of dermatological disorders. Its primary products include the XTRAC excimer laser and VTRAC lamp systems utilized in the treatment of psoriasis, vitiligo and various other skin conditions. Its operating segment includes Dermatology Recurring Procedures which is the key revenue driver and Dermatology Procedures Equipment. The Dermatology Recurring Procedures segment derives its revenues from the usage of its equipment by dermatologists to perform XTRAC procedures. Its Dermatology Procedures Equipment segment generates revenues from the sale of equipment, such as lasers and lamp products. Geographically, it derives a majority of revenue from the United states.